These include mutations in the SF3B1, SRSF2 and U2AF1 genes, from which mutations in the former two genes have been described in SM at relatively high frequencies in SM (Table 5) and/or (i.e., SRSF2) in association with poorer outcomes [11,96]. The gene discussed is U2AF1; the disease is systemic mastocytosis.